Presbyterian St. Luke's Offers Advanced Blood Cancer Radiation
The Denver hospital is the first in Colorado to provide total marrow and lymphoid irradiation for patients undergoing donor stem cell transplants.
Updated on Nov. 19, 2026 in Diseases

Live Poll
Would you trust a local hospital's advanced cancer treatments?
Presbyterian St. Luke's in Denver has begun offering total marrow and lymphoid irradiation for blood cancer patients. The hospital treated its first patient with the therapy on November 2, 2026.
Why it matters
The treatment targets radiation at the bone marrow and lymphatic system while reducing exposure to the heart, lungs and kidneys. It is offered to select patients with high-risk blood cancers, cancers that have returned, or cancers that have resisted other treatment.
The announcement reports one hospital in Colorado as the first to offer the treatment and one patient treated to date, with no outcome data yet available. Results for the treated patient and the program's broader effectiveness have not been disclosed.
The players
Presbyterian St. Luke's
A Denver hospital within the Kaiser Permanente system that provides a range of cancer and specialty care services.
Colorado Blood Cancer Institute
A Colorado research and treatment organization focused on blood cancers and stem cell transplantation.
Kaiser Permanente
A large nonprofit integrated healthcare system operating hospitals and medical groups across several states.
The details
Total marrow and lymphoid irradiation is used alongside donor stem cell transplants and is compared with total body irradiation, which delivers radiation to the whole body. The approach allows higher radiation doses to targeted tissues while limiting exposure to surrounding organs. The program was introduced through a collaboration between the hospital, Colorado Blood Cancer Institute, and Kaiser Permanente physicians and clinical teams, with specialists in radiation oncology, stem cell transplantation and medical physics involved.
Timeline
November 2, 2026: Presbyterian St. Luke's treats its first patient with total marrow and lymphoid irradiation.
November 19, 2026: The hospital announces the new treatment offering.
Health Landscape
Total marrow and lymphoid irradiation is positioned as a refinement of total body irradiation, the long-standing conditioning method used before donor stem cell transplants. The shift reflects a broader move in blood cancer care toward targeted radiation that limits harm to the heart, lungs and kidneys.
Patients with high-risk blood cancers or cancers that have returned may ask their oncology teams whether targeted radiation options such as total marrow and lymphoid irradiation are appropriate for them. Eligibility is limited to select patients, so the treatment is not available to everyone who has a blood cancer.
The takeaway
Targeted radiation is becoming a more precise option in blood cancer care, but its use depends on careful patient selection by specialist teams. Patients considering stem cell transplants can ask their doctors whether advanced radiation approaches are available and suitable for their diagnosis.
Further reading
For more on treatment developments, explore Cancer coverage on Wisevoter.
Source note: This article includes information reported by ColoradoBiz.
Live Poll
Would you trust a local hospital's advanced cancer treatments?






